3min chapter

The Intelligence from The Economist cover image

It’s no longer Trudeau: Canada’s PM resigns

The Intelligence from The Economist

CHAPTER

Challenges and Optimism in AI-Driven Drug Development

This chapter explores the intricate challenges of drug development and the role of AI technologies in this process. It offers a cautiously optimistic perspective on AI's potential to improve drug approval rates, despite recent hurdles faced by AI-driven startups in clinical trials.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode